Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Clostridium difficile infection in HIV-seropositive individuals and transplant recipients.

Collini PJ, Bauer M, Kuijper E, Dockrell DH.

J Infect. 2012 Feb;64(2):131-47. doi: 10.1016/j.jinf.2011.12.003. Epub 2011 Dec 9. Review.

PMID:
22178989
2.

Clostridium difficile infection in cancer patients and hematopoietic stem cell transplant recipients.

Chopra T, Alangaden GJ, Chandrasekar P.

Expert Rev Anti Infect Ther. 2010 Oct;8(10):1113-9. doi: 10.1586/eri.10.95. Review.

PMID:
20954878
3.

Recent epidemiology of Clostridium difficile infection during hematopoietic stem cell transplantation.

Chopra T, Chandrasekar P, Salimnia H, Heilbrun LK, Smith D, Alangaden GJ.

Clin Transplant. 2011 Jan-Feb;25(1):E82-7. doi: 10.1111/j.1399-0012.2010.01331.x. Epub 2010 Oct 25.

4.

[Immunosuppressive treatment as a risk factor for the occurrence of clostridium difficile infection (CDI)].

Lübbert C, Johann C, Kekulé AS, Worlitzsch D, Weis S, Mössner J, Behl S, Seufferlein T.

Z Gastroenterol. 2013 Nov;51(11):1251-8. doi: 10.1055/s-0033-1335505. Epub 2013 May 21. German.

PMID:
23696115
5.

Calcineurin inhibitors and Clostridium difficile infection in adult lung transplant recipients: the effect of cyclosporine versus tacrolimus.

Lee JT, Whitson BA, Kelly RF, D'Cunha J, Dunitz JM, Hertz MI, Shumway SJ.

J Surg Res. 2013 Sep;184(1):599-604. doi: 10.1016/j.jss.2013.03.041. Epub 2013 Apr 2.

PMID:
23566442
6.

Clostridium difficile infection in non-HIV-immunocompromised patients and in HIV-infected patients.

Raines DL, Lopez FA.

Curr Gastroenterol Rep. 2011 Aug;13(4):344-50. doi: 10.1007/s11894-011-0196-6. Review.

PMID:
21541693
7.

Clostridium difficile infection increases mortality risk in lung transplant recipients.

Lee JT, Kelly RF, Hertz MI, Dunitz JM, Shumway SJ.

J Heart Lung Transplant. 2013 Oct;32(10):1020-6. doi: 10.1016/j.healun.2013.06.012. Epub 2013 Jul 23.

PMID:
23891145
8.

Risk factors for recurrent Clostridium difficile infection in hematopoietic stem cell transplant recipients.

Huang AM, Marini BL, Frame D, Aronoff DM, Nagel JL.

Transpl Infect Dis. 2014 Oct;16(5):744-50. doi: 10.1111/tid.12267. Epub 2014 Jul 18.

PMID:
25040545
9.

Clostridium difficile infection in patients with HIV/AIDS.

Collini PJ, Kuijper E, Dockrell DH.

Curr HIV/AIDS Rep. 2013 Sep;10(3):273-82. doi: 10.1007/s11904-013-0162-z. Review.

PMID:
23657793
10.

Clostridium difficile infection among hematopoietic stem cell transplant recipients: beyond colitis.

Alonso CD, Marr KA.

Curr Opin Infect Dis. 2013 Aug;26(4):326-31. doi: 10.1097/QCO.0b013e3283630c4c. Review.

11.

Epidemiology and clinical characteristics of Clostridium difficile infection in a Korean tertiary hospital.

Kim J, Pai H, Seo MR, Kang JO.

J Korean Med Sci. 2011 Oct;26(10):1258-64. doi: 10.3346/jkms.2011.26.10.1258. Epub 2011 Oct 1.

12.

Fecal microbiota transplantation (FMT) for Clostridium difficile infection: focus on immunocompromised patients.

Di Bella S, Gouliouris T, Petrosillo N.

J Infect Chemother. 2015 Apr;21(4):230-7. doi: 10.1016/j.jiac.2015.01.011. Epub 2015 Jan 31. Review.

PMID:
25703532
13.

Clostridium difficile infection after allogeneic hematopoietic stem cell transplantation: incidence, risk factors, and outcome.

Willems L, Porcher R, Lafaurie M, Casin I, Robin M, Xhaard A, Andreoli AL, Rodriguez-Otero P, Dhedin N, Socié G, Ribaud P, Peffault de Latour R.

Biol Blood Marrow Transplant. 2012 Aug;18(8):1295-301. doi: 10.1016/j.bbmt.2012.02.010. Epub 2012 Feb 28.

14.

Mouse relapse model of Clostridium difficile infection.

Sun X, Wang H, Zhang Y, Chen K, Davis B, Feng H.

Infect Immun. 2011 Jul;79(7):2856-64. doi: 10.1128/IAI.01336-10. Epub 2011 May 16.

15.

Clostridium difficile: an emerging pathogen in children.

Khalaf N, Crews JD, DuPont HL, Koo HL.

Discov Med. 2012 Aug;14(75):105-13. Review.

16.

Clostridium difficile infection in solid organ transplant recipients.

Riddle DJ, Dubberke ER.

Curr Opin Organ Transplant. 2008 Dec;13(6):592-600. doi: 10.1097/MOT.0b013e3283186b51. Review.

PMID:
19060548
17.

Early Clostridium difficile infection during allogeneic hematopoietic stem cell transplantation.

Kinnebrew MA, Lee YJ, Jenq RR, Lipuma L, Littmann ER, Gobourne A, No D, van den Brink M, Pamer EG, Taur Y.

PLoS One. 2014 Mar 24;9(3):e90158. doi: 10.1371/journal.pone.0090158. eCollection 2014.

18.

Fecal microbiota transplantation for fulminant Clostridium difficile infection in an allogeneic stem cell transplant patient.

Neemann K, Eichele DD, Smith PW, Bociek R, Akhtari M, Freifeld A.

Transpl Infect Dis. 2012 Dec;14(6):E161-5. doi: 10.1111/tid.12017. Epub 2012 Nov 2.

PMID:
23121625
19.

Epidemiology and outcomes of Clostridium difficile infections in hematopoietic stem cell transplant recipients.

Alonso CD, Treadway SB, Hanna DB, Huff CA, Neofytos D, Carroll KC, Marr KA.

Clin Infect Dis. 2012 Apr;54(8):1053-63. doi: 10.1093/cid/cir1035. Epub 2012 Mar 12.

20.

Liver graft failure and hyperbilirubinemia in liver transplantation recipients after Clostridium difficile infection.

Rochon C, Kardashian A, Mahadevappa B, Gunasekaran G, Sharma J, Sheiner P.

Transplant Proc. 2011 Dec;43(10):3819-23. doi: 10.1016/j.transproceed.2011.08.098.

PMID:
22172853
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk